MYL12B Antibody

About the Target

MYL12B (Myosin Light Chain 12B), also known as MLC-B or MRLC2, is a regulatory light chain of the myosin II complex and plays a critical role in controlling actomyosin contractility in both smooth muscle and non-muscle cells. As part of the EF-hand calcium-binding protein superfamily, MYL12B contains a conserved structure featuring an N-terminal motor domain that interacts with actin, a central "neck" region with isoleucine-glutamine (IQ) motifs that bind calmodulin and modulate motor activity, and a C-terminal tail important for protein-protein interactions and regulation. Depending on the literature source, MYL12B may also be discussed as MRLC2 and Myosin regulatory light chain 12B.

Reported cellular context includes cytoplasm, which can matter when signal is compared across treatments or changing cell states. Following MYL12B across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

MYL12B is commonly interpreted in the context of inflammation research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cytoplasm, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

• signal enrichment within cytoplasm relative to the broader cellular background
• responses associated with cytokine exposure, inflammatory tone, or tissue stress
• co-patterning with orthogonal markers and control conditions that clarify pathway state
• time-matched comparisons so changes reflect biology rather than handling or sampling drift

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for MYL12B. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in MYL12B reflect biology rather than handling. When interpreting MYL12B, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep MYL12B trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.